Company Filing History:
Years Active: 2015-2025
Title: **Mathias Krusch: Innovator in Pharmaceutical Chemistry**
Introduction
Mathias Krusch, based in Hirschhorn, Germany, is an accomplished inventor with a significant contribution to the field of pharmaceutical chemistry. He holds eight patents, reflecting his dedication to innovation and development within the industry.
Latest Patents
Among his latest patents are two notable inventions. The first is related to PTH prodrugs, which encompass pharmaceutical compositions that include such PTH prodrugs and their various uses. The second patent focuses on a controlled-release parathyroid hormone (PTH) compound, where PTH(1-34) is reversibly conjugated to branched polyethylene glycol. This innovative compound is vital for the treatment, control, delay, or prevention of conditions manageable with PTH.
Career Highlights
Mathias Krusch has garnered experience working with reputable companies such as Ascendis Pharma Bone Diseases A/S and Ascendis Pharma A/S. His role in these organizations solidifies his reputation as a pivotal player in the development of effective pharmaceutical solutions.
Collaborations
Throughout his career, Krusch has collaborated with talented professionals, including Kennett Sprogøe and Felix Cleemann. These partnerships have further enriched his innovative projects, leading to significant advancements in pharmaceutical technologies.
Conclusion
In conclusion, Mathias Krusch stands out as an influential inventor in the realm of pharmaceutical innovations. His dedication to advancing drug therapies through his patented inventions illustrates the impact of his work on medical treatments and patient care. As he continues to innovate, Mathias Krusch remains a key figure in the pharmaceutical industry.